Evening Chronotype Linked to Later Eating and Higher Body Fat

Healthy women with an evening chronotype—individuals who naturally prefer later sleep and meal times—show higher body fat percentages and less favorable metabolic markers compared to those with morning or intermediate preferences, according to a study published in Frontiers in Nutrition. Research from the PROMISE study indicates that meal timing, particularly the consumption of energy late … Read more

New Prolactinoma Management Guidelines: Updated Clinical Consensus

A multidisciplinary panel of 60 specialists has released the 2025 edition of the Chinese consensus on the diagnosis and treatment of prolactinomas, published in the Chinese Neurosurgical Journal on June 8, 2026. This evidence-based framework standardizes care across endocrinology, neurosurgery, and radiology to improve early detection and patient outcomes for the most common hormone-secreting pituitary … Read more

Early Menopause Persists in Low- and Middle-Income Countries

Early menopause affects approximately 1 in 14 women aged 30 to 49 in low and middle income countries, according to a pooled data analysis of 44 nations published in BMJ Global Health. The study finds that prevalence is consistently higher in rural areas, while higher education levels and delayed childbearing significantly reduce the risk. Why … Read more

Shared Gene Signatures Reveal How Mammals Age

The Biological Age Revolution: How Universal Molecular Clocks are Rewriting the Rules of Longevity For decades, we have treated aging as an inevitable, unstoppable march of time—a simple matter of birthdays and wrinkles. But what if aging isn’t a fixed destination, but a measurable, biological process that can be tracked, predicted, and potentially slowed? Recent … Read more

New “Trojan Horse” Drug Dramatically Boosts Weight Loss Results

The landscape of metabolic medicine is undergoing a seismic shift. For years, blockbuster weight-loss drugs like GLP-1 and GIP agonists have dominated the conversation, offering a lifeline to millions struggling with obesity and type 2 diabetes. Yet, scientists are already looking toward the next frontier: “precision pharmacology.” The “Trojan Horse” Revolution in Weight Loss Researchers … Read more

Liver cancer burden rising globally amid shift to metabolic risks

The Looming Liver Cancer Crisis: A Global Shift in Risk Factors Liver cancer remains a significant global health threat, ranking as the third leading cause of cancer-related deaths worldwide. In 2022 alone, nearly 870,000 new cases were reported, with hepatocellular carcinoma accounting for almost 80% of these. A concerning trend is emerging: even as progress … Read more

CDC Reports on Prevalence of Obesity, Severe Obesity in US Adults, Children

Obesity Rates Soar in US: A Deep Dive into the Growing Crisis The United States is facing a significant public health challenge: rising obesity rates among both adults and children. Recent data from the National Center for Health Statistics reveals a marked increase in prevalence over recent decades, prompting concerns about long-term health consequences and … Read more

Sperm RNA aging shift that may explain paternal age effects

The Ticking Clock in Sperm: How RNA ‘Aging Cliffs’ Could Reshape Fertility and Beyond For decades, the impact of paternal age on offspring health has been a growing concern. We’ve known older fathers face a slightly increased risk of children with certain developmental and neuropsychiatric conditions. But why? Recent research, pinpointing a dramatic shift in … Read more

TLC-2716/6665: Preclinical & Phase 1 Data on a Novel LXR Agonist for Dyslipidemia & NASH

The Future of Metabolic Disease Treatment: Beyond Statins and Towards Precision Therapies The fight against metabolic diseases like type 2 diabetes, non-alcoholic steatohepatitis (NASH), and hyperlipidemia is entering a new era. Recent research, detailed in studies examining compounds like TLC-2716 and TLC-6665, points towards a future where treatments aren’t one-size-fits-all, but tailored to individual genetic … Read more

Multi-omics Reveals a Metabolome-Driven Signature for Defining Metabolic Obesity & Predicting Risk

Beyond the BMI: How ‘Metabolic BMI’ Could Revolutionize Obesity Treatment For decades, Body Mass Index (BMI) has been the go-to metric for assessing weight and health risk. But a groundbreaking study, published recently and analyzing data from over 1,400 individuals, suggests BMI alone paints an incomplete picture. Researchers have developed a new measure, dubbed “metBMI,” … Read more